applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.
Company profile
Ticker
APLT
Exchange
Website
CEO
Shoshana Shendelman
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Applied Therapeutics Inc.
SEC CIK
APLT stock data
Latest filings (excl ownership)
S-3
Shelf registration
22 Mar 24
D
$100.00 mm in equity / options, sold $100.00 mm, 31 investors
13 Mar 24
8-K
Regulation FD Disclosure
11 Mar 24
10-K
2023 FY
Annual report
6 Mar 24
8-K
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
6 Mar 24
8-K
Applied Therapeutics Announces $100 Million Private Placement
29 Feb 24
8-K
Other Events
15 Feb 24
UPLOAD
Letter from SEC
31 Jan 24
CORRESP
Correspondence with SEC
25 Jan 24
8-K
Other Events
4 Jan 24
Latest ownership filings
4
Shoshana Shendelman
18 Mar 24
4
Riccardo Perfetti
18 Mar 24
4
Adam Hansard
18 Mar 24
4
Leslie D. Funtleyder
18 Mar 24
4
Constantine Chinoporos
18 Mar 24
3
Constantine Chinoporos
18 Mar 24
SC 13G
JANUS HENDERSON GROUP PLC
8 Mar 24
SC 13D/A
Shendelman Shoshana
5 Mar 24
SC 13G/A
Propel Bio Management, LLC
22 Feb 24
SC 13G/A
Venrock Healthcare Capital Partners III, L.P.
14 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 37.46 mm | 37.46 mm | 37.46 mm | 37.46 mm | 37.46 mm | 37.46 mm |
Cash burn (monthly) | (no burn) | 244.25 k | 5.17 mm | 5.21 mm | 4.91 mm | 4.51 mm |
Cash used (since last report) | n/a | 1.45 mm | 30.76 mm | 31.02 mm | 29.24 mm | 26.83 mm |
Cash remaining | n/a | 36.00 mm | 6.69 mm | 6.43 mm | 8.22 mm | 10.62 mm |
Runway (months of cash) | n/a | 147.4 | 1.3 | 1.2 | 1.7 | 2.4 |
Institutional ownership, Q2 2023
46.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 40 |
Opened positions | 9 |
Closed positions | 5 |
Increased positions | 13 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 34.97 bn |
Total shares | 48.74 mm |
Total puts | 600.00 |
Total calls | 7.52 mm |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
ARE Alexandria Real Estate Equities | 13.43 mm | $10.88 mm |
BEN Franklin Resources | 7.95 mm | $10.17 bn |
Venrock Healthcare Capital Partners III | 5.80 mm | $8.81 mm |
VR Adviser | 5.66 mm | $7.24 bn |
Alyeska Investment | 4.43 mm | $5.67 bn |
FMR | 2.64 mm | $3.38 bn |
Simplify Asset Management | 2.38 mm | $3.05 bn |
Shendelman Shoshana | 1.49 mm | $806.00 k |
Vanguard | 997.00 k | $1.28 bn |
Rock Springs Capital Management | 780.79 k | $999.41 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Mar 24 | Adam Hansard | Common Stock | Sell | Dispose S | No | No | 5.39 | 48,871 | 263.41 k | 732,919 |
14 Mar 24 | Funtleyder Leslie D. | Common Stock | Sell | Dispose S | No | No | 5.39 | 28,727 | 154.84 k | 308,421 |
14 Mar 24 | Riccardo Perfetti | Common Stock | Sell | Dispose S | No | No | 5.39 | 110,804 | 597.23 k | 1,031,537 |
14 Mar 24 | Shendelman Shoshana | Common Stock | Sell | Dispose S | No | No | 5.39 | 318,573 | 1.72 mm | 3,817,814 |
News
RBC Capital Initiates Coverage On Applied Therapeutics with Outperform Rating, Announces Price Target of $12
26 Mar 24
UBS Maintains Buy on Applied Therapeutics, Raises Price Target to $13
15 Mar 24
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
11 Mar 24
UBS Maintains Buy on Applied Therapeutics, Raises Price Target to $12
6 Mar 24
Applied Therapeutics: Q4 Earnings Insights
6 Mar 24
Press releases
Applied Therapeutics Announces $100 Million Private Placement
28 Feb 24
Thinking about buying stock in Angion Biomedica, Ardelyx, AMC Entertainment, Applied Therapeutics, or Wisekey International Holding ?
9 Jan 24
Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy
4 Jan 24
Thinking about buying stock in Omega Therapeutics, Eli Lilly And Co, Cisco Systems, Applied Therapeutics, or Brooge Energy?
4 Jan 24
Thinking about buying stock in Dyne Therapeutics, Applied Therapeutics, ON Semiconductor, Mereo BioPharma, or Neximmune?
3 Jan 24